In this issue:

Janssen Uses Insilico’s Digital Twins for Cell Culture

NIH Awards The University of Georgia Up to $130 Million for Flu Vaccine

JM Canty International and NIBRT Team Up for Optical System Research Collaboration

Top Stories

AstraZeneca Announces Sale of Acid Reduction Drug for $243 Million

The $243 million will be paid upon completion of the agreements along with sales-contingent milestones of up to $33 million in 2021 and 2022.
/ read more /

GSK Invests $120 million in
US Biopharmaceutical Manufacturing Facility

GSK’s expanded R&D and manufacturing facility in Upper Merion, PA houses a new analytical lab and flexible manufacturing equipment, including single-use bioreactors.
/ read more /

Industry News

NIH Awards The University of Georgia Up to $130 Million for Flu Vaccine

The project will focus on the development of an influenza vaccine that protects against multiple strains of the influenza virus in a single dose.
/ read more /

BIA to Hold Events Aimed at Preparing Life
Sciences Businesses for Brexit

BIA will be hosting a series of events and webinars to support small-and-medium sized enterprises in life sciences in the preparations for a possible ‘no-deal’ Brexit.
/ read more /

Supplier News

TrakCel Forms Cell and Gene Therapy Supply Partnership with WuXi AppTec

The partnership combines global CDMO services with a cellular orchestration platform
/ read more /

JM Canty International and NIBRT Team Up for Optical System Research Collaboration

The companies plan to collaborate for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.
/ read more /

Bio/Pharma News

Janssen Uses Insilico’s Digital Twins for Cell Culture

Janssen will use Inisilico’s digital models of cells to accelerate cell-line development for biologics manufacturing.
/ read more /

Problems With Ranitidine May Transcend
Manufacturing Issues

The root cause of NDMA contamination may go well beyond manufacturing problems, to the molecule itself.
/ read more /